Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases.

Grote, Stefan; Traub, Frank; Mittelstaet, Joerg; Seitz, Christian; Kaiser, Andrew; Handgretinger, Rupert; Schleicher, Sabine

Grote, Stefan; Traub, Frank; Mittelstaet, Joerg; Seitz, Christian; Kaiser, Andrew; Handgretinger, Rupert; Schleicher, Sabine.

Afiliação

Grote S; Department of Hematology and Oncology, University Hospital Tuebingen, Children's Hospital, 72076 Tuebingen, Germany.
Traub F; Department of Orthopedics and Traumatology, University Medical Center Mainz, Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
Mittelstaet J; Miltenyi Biotec GmbH, 51429 Bergisch Gladbach, Germany.
Seitz C; Department of Hematology and Oncology, University Hospital Tuebingen, Children's Hospital, 72076 Tuebingen, Germany.
Kaiser A; Miltenyi Biotec GmbH, 51429 Bergisch Gladbach, Germany.
Handgretinger R; Department of Hematology and Oncology, University Hospital Tuebingen, Children's Hospital, 72076 Tuebingen, Germany.
Schleicher S; Department of Hematology and Oncology, University Hospital Tuebingen, Children's Hospital, 72076 Tuebingen, Germany.

Cancers (Basel) ; 13(5)2021 Mar 05.

Article em En | MEDLINE | ID: mdl-33807875

Palavras-chave

NK-92; adapter; bone metastasis; chimeric antigen receptor; solid tumors

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google